White Papers

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19

The development of medicines for Expanded Access or Compassionate Use in the treatment of serious diseases with no approved treatment – COVID-19 The World Health Organiz

Optimize your ADME/hAME study to overcome barriers and avoid delays for drug development success

The Optimize your ADMA/hAME study to overcome barriers and avoid delays for drug development success Optimization of human absorption, metabolism, and excretion (hAME) stu